Paclitaxel Protein-Bound Particles 69097-0398-78

Package NDC

69097-0398-78

Manufacturer: Cipla Usa Inc.
Dosage Form: Injection, Powder, Lyophilized, For Suspension
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: April 15, 2025
Listing Expires: December 31, 2026
Application: ANDA209657

Need to source Paclitaxel Protein-Bound Particles? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Paclitaxel	100 mg/20mL

Drug Class

Microtubule Inhibitor [EPC]Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Selected Package

69097-0398-78Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (69097-398-78) / 20 mL in 1 VIAL, SINGLE-DOSE